News Conference News TCT 2023 Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out Michael O'Riordan October 25, 2023
News Conference News TCT 2021 No Harm From Thrombolytics in SCAD Patients With STEMI Michael O'Riordan October 13, 2021
News Conference News AHA 2020 OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP Shelley Wood November 14, 2020
News Conference News ACC 2018 ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More Shelley Wood March 11, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Conference News AHA 2017 Global Improvement in ACS Care Seen With Regional Clinical Pathway Implementation Yael L. Maxwell November 27, 2017
News Conference News TCT 2016 Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI Yael L. Maxwell October 31, 2016
News Conference News EuroPCR 2016 From Italy to Bangladesh: STEMI Networks Matter Caitlin E. Cox May 18, 2016
News Conference News ACC 2016 More Evidence That Morphine Hampers Effects of Antiplatelet Therapy in STEMI Todd Neale April 02, 2016
News Conference News ESC 2014 SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS Yael L. Maxwell August 31, 2014
News Conference News AHA 2013 STREAM: Pre-hospital Fibrinolysis Strategy as Safe as Primary PCI at 1 Year in STEMI Yael L. Maxwell November 18, 2013
News Conference News ACC 2013 STREAM: Fibrinolysis Strategy Effective for STEMI Patients Far From PCI Hospital Yael L. Maxwell March 09, 2013
News Conference News ESC 2012 Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients Caitlin E. Cox August 27, 2012
News Conference News ESC 2012 ESC Congress 2012 Offers Slate of Guidelines, New MI Definition Caitlin E. Cox August 26, 2012
News Conference News Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS September 02, 2011